REGNANTE KEITH (Chief Financial Officer) received a stock award from KEROS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2025ACC: 0001415889-25-004597
Officer· Chief Financial Officer
Since Apr 2020
+44K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
44K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+44K
Price / share
—
Trade value
—
% of position
New position
2/18/2025
0.00→44K
Total
Net shares
+44K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2025 | A · Award | +44K | — | — | New position | 0.00 | 44K |
| Total | +44K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported